Stockscreener 앱 받기
80.11
5.61%
-4.76
시간 외 거래:
80.00
-0.11
-0.14%
전일 마감가:
$84.87
열려 있는:
$79.62
하루 거래량:
772.32K
Relative Volume:
0.79
시가총액:
$2.25B
수익:
$267.23M
순이익/손실:
$-83.50M
주가수익비율:
-25.76
EPS:
-3.11
순현금흐름:
$-59.99M
1주 성능:
-15.08%
1개월 성능:
-15.09%
6개월 성능:
+70.01%
1년 성능:
+747.72%
1일 변동 폭
$78.00
$82.59
1주일 범위
$78.00
$94.23
52주 변동 폭
$8.6328
$115.60
Genedx Holdings Corp Stock (WGS) Company Profile
명칭
Genedx Holdings Corp
전화
888-729-1206
주소
333 LUDLOW STREET, STAMFORD
WGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
80.11 | 2.25B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
470.03 | 177.32B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
197.90 | 141.59B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
410.76 | 33.29B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.67 | 31.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
167.69 | 29.57B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-10 | 개시 | Craig Hallum | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
Why GeneDx Holdings Shares Are Under Pressure - TipRanks
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - Yahoo Finance
Prudential Financial Inc. Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx CEO Stueland sells $4.45 million in stock By Investing.com - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock By Investing.com - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock - Investing.com India
GeneDx CEO Stueland sells $4.45 million in stock - Investing.com India
GeneDx Holdings Corp. Executives Sell Shares to Cover Tax Obligations - TradingView
Victory Capital Management Inc. Acquires Shares of 2,720 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
7 Up-and-Coming Stocks to Buy in 2025 - US News Money
How To Trade (WGS) - news.stocktradersdaily.com
3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2% - simplywall.st
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $96,416.32 in Stock - MarketBeat
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -March 20, 2025 at 04:52 pm EDT - Marketscreener.com
GeneDx Strengthens Team: 10 New Hires Receive Strategic Stock Awards Worth 46,340 RSUs - Stock Titan
Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba - Yahoo Finance
12 High Growth Low Debt Stocks to Invest in Now - Insider Monkey
Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)? - Yahoo Finance
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies - Yahoo Finance
GeneDx Revolutionizes Genome Sequencing with 48-Hour Results, Earns Top Innovation Honor - Stock Titan
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
Is GeneDx Holdings (NASDAQ:WGS) Using Too Much Debt? - Simply Wall St
Raymond James Financial Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
3,501 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Arizona State Retirement System - Defense World
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Drops By 43.2% - Defense World
Is GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025? - Insider Monkey
Revolutionary AI Tool by GeneDx Transforms Genetic Testing with 750,000 Clinical Sequences - StockTitan
Revolutionary AI Tool Transforms Genomic Analysis: GeneDx Leads Innovation at ACMG 2025 - Stock Titan
GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich (NASDAQ:WGS) - Seeking Alpha
Genedx CFO Kevin Feeley sells shares worth $87k By Investing.com - Investing.com Australia
GeneDx CEO Katherine Stueland sells $258,695 in company stock By Investing.com - Investing.com South Africa
12 Best Multibagger Stocks to Buy in 2025 - Insider Monkey
Genedx CFO Kevin Feeley sells shares worth $87k - Investing.com
GeneDx CEO Katherine Stueland sells $258,695 in company stock - Investing.com
Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now? - Insider Monkey
10 Best Emerging Technology Stocks to Buy Now - Insider Monkey
Lisanti Capital Growth LLC Raises Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics By Investing.com - Investing.com South Africa
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics - Investing.com India
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Principal Financial Group Inc. - Defense World
Rhumbline Advisers Buys 1,021 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Shares Surge Amid Strong Prospects - TipRanks
GeneDx Expanding Genetic Testing to Include Cerebral Palsy -March 04, 2025 at 09:53 am EST - Marketscreener.com
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Sees Significant Increase in Short Interest - Defense World
GeneDx Holdings Corp. (NASDAQ:WGSWW) Short Interest Update - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings CorpWGS - PR Newswire
An Investigation Has Commenced on Behalf of GeneDx Holdings Corp. Shareholders. Contact Levi & Korsinsky to Discuss your WGS Losses. - ACCESS Newswire
Genedx Holdings Corp (WGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.14%
1.59%
자본화:
|
볼륨(24시간):